Pharma stocks hit by Trump’s tariffs: Pharmaceutical stocks declined sharply by up to 5% on Friday, September 26, following US President Donald Trump's declaration of imposing 100% tariffs on branded and patent-protected medicines. Sun Pharma experienced the steepest decline, touching its yearly low at Rs 1,547, showing a 5% reduction from its last closing price. Biocon witnessed a 3.3% fall to Rs 344, whilst Zydus Lifesciences declined by 2.8%, settling at Rs 990. Aurobindo Pharma decreased by 2.4% to Rs 1,070, and Dr. Reddy's registered a 2.3% decline to Rs 1,245.30. Both Lupin and Cipla saw a 2% reduction, ending at Rs 1,923.30 and Rs 1,480, respectively. Torrent Pharma showed the smallest decline of 1.5%, reaching Rs 3,480.65. At approximately 9:30 am, the Nifty Pharma index
Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on D

51